文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

肺结节病中的混合性通气障碍:患病率与临床特征

Mixed Ventilatory Defects in Pulmonary Sarcoidosis: Prevalence and Clinical Features.
PubMed 文献 · Chest · 2020-06-12
一句话结论在肺结节病患者中,混合性通气障碍在气流阻塞者中约占25%,且与更低的弥散功能、更高的IV期影像比例及更高死亡率相关。

该研究纳入1110例肺结节病患者,按美国胸科学会/欧洲呼吸学会标准定义混合性通气障碍,从临床记录中提取临床数据、肺功能变量和生存状态,并由两名经验丰富的放射科医师独立评估胸片。结果显示,全队列混合性通气障碍患病率为10.4%,在气流阻塞患者中升至25.9%。与单纯气流阻塞相比,混合性缺陷与更低的肺一氧化碳弥散量(50.7 ± 16.3 vs 70.8 ± 18.1;P < .0001)、更高的胸片IV期病变患病率(63.5% vs 38.3%;P < .0001)及更高的死亡率(风险比2.36;95%CI 1.34-4.15;P = .003)相关,且这些发现在所有亚组分析中均得到重复。作者认为这识别出一种与混合性通气障碍相关的独特表型,值得未来研究其临床和病理生理意义。

要点

  • 在肺结节病合并气流阻塞的患者中,混合性通气障碍的患病率为25.9%,全队列为10.4%。
  • 与单纯气流阻塞相比,混合性缺陷患者肺一氧化碳弥散量更低(50.7 ± 16.3 vs 70.8 ± 18.1;P < .0001)。
  • 混合性缺陷患者胸片IV期病变患病率更高(63.5% vs 38.3%;P < .0001)。
  • 混合性缺陷与更高的死亡率相关(风险比2.36;95%CI 1.34-4.15;P = .003)。
  • 上述发现在组织学诊断、临床诊断、新发和 prevalent 病患者的所有亚组分析中均得到重复。

适用人群与场景

  • 肺结节病患者(N = 1,110),包括组织学诊断、临床诊断、新发和 prevalent 病患者。

诊断标准与关键阈值

  • 混合性通气障碍根据美国胸科学会/欧洲呼吸学会标准定义。

研究设计与关键结果

  • 研究类型为队列研究,样本量N = 1,110,人群为肺结节病患者。
  • 全队列混合性通气障碍患病率为10.4%,在气流阻塞患者中为25.9%。
  • 与单纯气流阻塞相比,混合性缺陷患者肺一氧化碳弥散量更低(50.7 ± 16.3 vs 70.8 ± 18.1;P < .0001)。
  • 混合性缺陷患者胸片IV期病变患病率更高(63.5% vs 38.3%;P < .0001)。
  • 混合性缺陷与更高的死亡率相关(风险比2.36;95%CI 1.34-4.15;P = .003)。
  • 上述发现在所有患者亚组分析中均得到重复,包括组织学诊断、临床诊断、新发疾病和 prevalent 疾病患者。

证据类型、等级与局限

  • 证据类型:队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 在肺结节病合并气流阻塞的患者中,应识别混合性通气障碍表型,因其与更低的弥散功能、更高的IV期影像比例及更高死亡率相关。
  • 作者认为这些观察识别出一种与混合性通气障碍相关的独特表型,值得未来研究其临床和病理生理意义。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: In cohort studies of pulmonary sarcoidosis, abnormal ventilatory patterns have generally been subdivided into restrictive and obstructive defects. Mixed ventilatory defects have largely been overlooked in pulmonary sarcoidosis, as total lung capacity has seldom been taken into account in historical series.

RESEARCH QUESTION: This study evaluated the prevalence of mixed disease in pulmonary sarcoidosis and its clinical associations.

STUDY DESIGN AND METHODS: In patients with pulmonary sarcoidosis (N = 1,110), mixed defects were defined according to American Thoracic Society/European Respiratory Society criteria. Clinical data, pulmonary function variables, and vital status were abstracted from clinical records. Chest radiographs were evaluated independently by two experienced radiologists.

RESULTS: The prevalence of a mixed ventilatory defect was 10.4% in the whole cohort, rising to 25.9% in patients with airflow obstruction. Compared with isolated airflow obstruction, mixed defects were associated with lower diffusing lung capacity for carbon monoxide levels (50.7 ± 16.3 vs 70.8 ± 18.1; P < .0001), a higher prevalence of chest radiographic stage IV disease (63.5% vs 38.3%; P < .0001), and higher mortality (hazard ratio, 2.36; 95% CI, 1.34-4.15; P = .003). These findings were reproduced in all patient subgroup analyses, including patients with a histologic diagnosis, a clinical diagnosis, incident disease, and prevalent disease.

INTERPRETATION: Mixed disease is present in approximately 25% of patients with pulmonary sarcoidosis and airflow obstruction and is associated with lower diffusing lung capacity for carbon monoxide levels, a higher prevalence of stage IV disease, and higher mortality than seen in a pure obstructive defect. These observations identify a distinct phenotype associated with a mixed ventilatory defect, justifying future studies of its clinical and pathogenetic significance.

来源:Chest,查看原文。版权归原作者所有。

参考来源

  1. Kouranos V, Ward S, Kokosi MA, et al. Mixed Ventilatory Defects in Pulmonary Sarcoidosis: Prevalence and Clinical Features. Chest. 2020. PMID: 32534908. doi:10.1016/j.chest.2020.04.074

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。